Paul De Schepper
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Inflammatory mediators and NSAID effects 5
- Antibiotics Pharmacokinetics and Efficacy 2
- Drug-Induced Hepatotoxicity and Protection 2
-
- Eicosanoids and Hypertension Pharmacology 3
- Co-authors
- Agnes Buntinx (2 shared papers)A. Vermeulen (2 shared papers)Vito Angelo Giagulli (2 shared papers)Emma Stoner (1 shared paper)Paul Michielsen (3 shared papers)F. Lamy (2 shared papers)C. Harvengt (2 shared papers)Aimee L. Dallob (3 shared papers)
- Journals
- The Journal of Clinical Pharmacology (4 papers)American Journal of Kidney Diseases (2 papers)Journal of the American Society of Nephrology (1 paper)British Journal of Clinical Pharmacology (1 paper)Inflammation Research (1 paper)
- Partner nations
- BelgiumUnited StatesSwitzerland
In The Last Decade
Paul De Schepper
15 papers receiving 314 citations
Peers
Comparison fields: 5 of 71
- Urology 57
- Pharmacology 105
- Endocrinology, Diabetes and Metabolism 77
- Pharmacology 36
- Biochemistry 23
Countries citing papers authored by Paul De Schepper
This map shows the geographic impact of Paul De Schepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul De Schepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul De Schepper more than expected).
Fields of papers citing papers by Paul De Schepper
This network shows the impact of papers produced by Paul De Schepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul De Schepper. The network helps show where Paul De Schepper may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul De Schepper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 94 | |
| 2 | 2003 | 78 | |
| 3 | 1985 | 32 | |
| 4 | 1988 | 27 | |
| 5 | 1973 | 25 | |
| 6 | 1991 | 23 | |
| 7 | 1958 | 20 | |
| 8 | 2001 | 17 | |
| 9 | 1973 | 16 | |
| 10 | 2003 | 9 | |
| 11 | 1999 | 6 | |
| 12 | 1996 | 5 | |
| 13 | 1996 | 4 | |
| 14 | 2003 | 1 | |
| 15 | Effect of chlorpropamide on hepatic triglyceride metabolism. | 1976 | 1 |
About Paul De Schepper
Paul De Schepper is a scholar working on Pharmacology, Biochemistry, Endocrinology, Diabetes and Metabolism, Pharmacology and Organic Chemistry, having authored 15 papers that have together received 358 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Hormonal and reproductive studies (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Synthesis of β-Lactam Compounds (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Sexual Differentiation and Disorders (2 papers) and Receptor Mechanisms and Signaling (1 paper). The work is most often cited by research in Urology (57 citations), Pharmacology (105 citations), Endocrinology, Diabetes and Metabolism (77 citations), Pharmacology (36 citations) and Biochemistry (23 citations). Paul De Schepper has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Agnes Buntinx, A. Vermeulen, Vito Angelo Giagulli, Emma Stoner, Paul Michielsen, F. Lamy, C. Harvengt, Aimee L. Dallob, Keith M Gottesdiener and Barry J. Gertz. Their work appears in journals such as The Journal of Clinical Pharmacology, American Journal of Kidney Diseases, Journal of the American Society of Nephrology, British Journal of Clinical Pharmacology and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.